Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Hypera
Market Cap: R$14.1b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.10
7D
-6.5%
1Y
-26.8%